Laniquidar

CAS No. 197509-46-9

Laniquidar( R-101933 | R101933 )

Catalog No. M13087 CAS No. 197509-46-9

An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1089 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Laniquidar
  • Note
    Research use only, not for human use.
  • Brief Description
    An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein.
  • Description
    An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein, resulting in higher concentrations of antineoplastic agents in tumor cells that are multi-drug resistant due to the overexpression of P-glycoprotein.Breast Cancer Phase 2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    R-101933 | R101933
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    P-glycoprotein
  • Recptor
    P-glycoprotein
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    197509-46-9
  • Formula Weight
    584.7
  • Molecular Formula
    C37H36N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CN=C2N1CCC3=CC=CC=C3/C2=C4CCN(CCC5=CC=C(OCC6=NC7=CC=CC=C7C=C6)C=C5)CC\4)OC
  • Chemical Name
    methyl 11-(1-(4-(quinolin-2-ylmethoxy)phenethyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine-3-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. van Zuylen L, et al. Clin Cancer Res. 2000 Apr;6(4):1365-71. 2. van Zuylen L, et al. Eur J Cancer. 2002 May;38(8):1090-9. 3. Luurtsema G, et al. Nucl Med Biol. 2009 Aug;36(6):643-9.
molnova catalog
related products
  • YS-370

    YS-370 is an orally active inhibitor of P-gp and shows moderate inhibition against CYP3A4. YS-370 effectively reverses multidrug resistance to paclitaxel and colchicine and exhibits stronger antitumor activity in combination with paclitaxel.

  • Alisol F 24-acetate

    Alisol F 24-acetate is a natural product isolated from Alisma plantago-aquatica Linn. Alisol F 24 Acetate enhances chemosensitivity and apoptosis of MCF-7/DOX Cells by inhibiting P-Glycoprotein-Mediated drug efflux.

  • Valspodar

    A highly potent multidrug-resistance modifier that acts as a P-glycoprotein inhibitor.